School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Medpace Holdings, Inc. MEDP

Healthcare · Diagnostics & Research

$612.05last close 2026-10-09 · market cap $17.08B · delayed data

Trailing returns

1M+4.39%
3M+14.30%
6M+22.04%
1Y+18.00%
5Y+224.18%

Basis: Adjusted daily closes.

What it does

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.

Open MEDP in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies